BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10532967)

  • 21. Percutaneous urinary drainage and ureteric stenting in malignant disease.
    Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease.
    Joyce M; Mignanelli E; Church J
    Dis Colon Rectum; 2010 Mar; 53(3):327-32. PubMed ID: 20173481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
    Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
    AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metallic ureteric stents: early experience.
    Pandian SS; Hussey JK; McClinton S
    Br J Urol; 1998 Dec; 82(6):791-7. PubMed ID: 9883213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory abdominal aortic aneurysm and bilateral complete ureteral obstruction: treatment by endovascular graft and bilateral ureteric stenting.
    Nevelsteen A; Lacroix H; Stockx L; Baert L; Depuydt P
    Ann Vasc Surg; 1999 Mar; 13(2):222-4. PubMed ID: 10072466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliation of obstructive nephropathy due to malignancy.
    Harrington KJ; Pandha HS; Kelly SA; Lambert HE; Jackson JE; Waxman J
    Br J Urol; 1995 Jul; 76(1):101-7. PubMed ID: 7544201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of antegrade stenting for lower ureteric obstruction.
    Jenkins CN; Marcus AJ
    J R Soc Med; 1995 Aug; 88(8):446-9. PubMed ID: 7562827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.
    Patel C; Loughran D; Jones R; Abdulmajed M; Shergill I
    BMC Urol; 2017 Mar; 17(1):16. PubMed ID: 28283031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrograde exchange of heavily encrusted ureteric stents via the ileal conduit: a technical report.
    Tapping CR; Boardman P
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):75-8. PubMed ID: 24529058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined antegrade and retrograde endoscopic approach for the management of urinary diversion-associated pathology.
    Delvecchio FC; Kuo RL; Iselin CE; Webster GD; Preminger GM
    J Endourol; 2000 Apr; 14(3):251-6. PubMed ID: 10795614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous antegrade ureteric stent insertion in malignant disease.
    Harding JR
    J R Soc Med; 1993 Sep; 86(9):511-3. PubMed ID: 8410885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extra-anatomic urinary diversion.
    Paterson PJ; Forrester A
    J Endourol; 1997 Dec; 11(6):411-2. PubMed ID: 9440850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous urinary diversion utilizing a nephrovesical stent: a superior alternative to long-term external drainage?
    Nakada SY; Gerber AJ; Wolf JS; Hicks ME; Picus D; Clayman RV
    Urology; 1995 Mar; 45(3):538-41. PubMed ID: 7879349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ureteric complications of renal transplantation.
    Kashi SH; Lodge JP; Giles GR; Irving HC
    Br J Urol; 1992 Aug; 70(2):139-43. PubMed ID: 1393435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.
    Mokhmalji H; Braun PM; Martinez Portillo FJ; Siegsmund M; Alken P; Köhrmann KU
    J Urol; 2001 Apr; 165(4):1088-92. PubMed ID: 11257644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous nephrostomy for ureteral obstruction in patients with gynecologic malignancy.
    Coddington CC; Thomas JR; Hoskins WJ
    Gynecol Oncol; 1984 Jul; 18(3):339-48. PubMed ID: 6204911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.